The slowdown in funding for the life sciences sector over the second half of 2022 has been pronounced. Carta, a firm that tracks startup investments, found that biotech seed funding, which hit quarterly peaks of roughly $400...more
What is the current situation in real estate as it relates to the life sciences industry? Simply put, the demand for space for both new and expanding life sciences companies is outstripping supply and is, in fact, at the...more